Delivery Order SPE2DB25D3012-SPE2DB25FXAEG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,558.78 to AmerisourceBergen Drug Corp for Erleada 60 mg tablets (120 count) on September 2, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price delivery order represents a non-competitive, non-set-aside award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a $7,558.78 delivery order to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120 count) with an ultimate completion date of May 23, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $7,558.78 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120-count units) on August 4, 2025, with completion scheduled for August 25, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical product...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,117.58 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets in quantities of 120 units. This non-competitive, firm fixed-price delivery order was awarded on July 18, 2025, with an ultimate completion date of August 8, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Erleada 60 mg tablets in a quantity of 120 units. This is a firm fixed-price delivery order with a ceiling value of $7,558.78 and an ultimate completion date of August 11, 2025. The contract utilizes no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $7,558.78 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120 count units) under a firm fixed price contract. The award, issued on September 5, 2025, with an ultimate completion date of September 26, 2025, carries no set-aside designation and represents a competitive award. AmerisourceBergen Drug Corp will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $14.7K delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Erleada 240 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 6, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among qualified vendors in the open market. This delivery...
- The Defense Logistics Agency awarded a $7,352.49 firm fixed price delivery order to AmerisourceBergen Drug Corp for Erleada 240 mg tablets (30-count units) under contract number 4569037002. The delivery order, which was competitively awarded with no set-aside designation, is scheduled for completion by August 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract action stemming from...
- The Defense Logistics Agency awarded a delivery order valued at $7,558.78 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120-count units) under a firm fixed-price contract with an ultimate completion date of October 8, 2025. This competitively awarded, non-set-aside delivery order will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. This...
- The Defense Logistics Agency awarded a $7,352.49 delivery order to AmerisourceBergen Drug Corp for the supply of Erleada 240 mg tablets (quantity 30s) under a firm fixed-price contract type. The contract, awarded on September 18, 2025, with an ultimate completion date of October 9, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXAEGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $37,793.90 for 120-count supplies of Erleada 60 mg tablets, with an ultimate completion date of October 8, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under a larger indefinite delivery vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialized medical commodities to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, is well-positioned to fulfill federal medical procurement needs for military and veteran healthcare systems, with a demonstrated track record of delivering diverse pharmaceutical products across multiple therapeutic domains through competitively awarded federal contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.8k | 9/17/25 |